# Neurava

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/neurava

- Industry: Medical Devices & Equipment
- Headquarters: West Lafayette, US
- Website: www.neurava.com
- Total disclosed funding: $1.9M
- Latest round: Seed (Aug 24, 2023)
- Investors on record: 5

## About

Based in Indiana, US, and co-founded by Jay Shah (CEO) and Vivek Ganesh (CTO) in 2019, Neurava, Inc. operates as a medical devices and equipment company specializing in the development of wearable medical devices for monitoring of seizures in persons with epilepsy. In April 2024, the firm raised USD 2.26 million in seed funding led by investor Life Science Angels, with participation from other investors UCB, Purdue Innovates, Elevate Ventures, Rivermount Ventures, and First Leaf Capital.

The company‘s flagship product is a smart wearable device equipped with advanced sensors to track epilepsy-related signals and detect potential seizure events. This device offers comprehensive monitoring, including nighttime surveillance, to provide caregivers with timely alerts and facilitate proactive treatment strategies. By seamlessly transmitting data to physicians, Neurava's technology expedites the formulation of personalized treatment and management plans for patients.

The company plans to utilize the April 2024 funding to finish a crucial usability study in adult and pediatric epilepsy patients at prestigious healthcare facilities.

## Funding rounds

- Seed, Aug 24, 2023, $0.7M — UCB S.A., Life Science Angels, Inc., Elevate Ventures, First Leaf Capital, Purdue Innovates
- Seed, Dec 22, 2022, $1.2M — UCB S.A., Life Science Angels, Inc., Elevate Ventures, First Leaf Capital, Purdue Innovates

## Investors

- UCB S.A. — Seed
- Life Science Angels, Inc. — Seed
- Elevate Ventures (https://capitalatlas.ai/funds/elevate-ventures) — Seed
- First Leaf Capital (https://capitalatlas.ai/funds/first-leaf-capital) — Seed
- Purdue Innovates — Seed